|
|
 |
|
Viewing report
|
|
|
|
Therapeutic Strategies in Heart Failure
Clinical Publishing, Oct 2007, Pages: 256
Therapeutic Strategies in Heart Failure is a pragmatic textbook written by active clinicians and investigators that is sharply focused on what the doctor needs to know to achieve the best possible outcome in patients with heart failure. The authors have incorporated all of the most recent definitive trial data, in a user friendly format, with frequent summary boxes and highlighted points of emphasis. The book begins with the prevention of heart failure, discusses best application of standard therapies, describes progress with current cutting edge treatments, and anticipates future therapeutic interventions. To complete the thought process, the final section deals with the avant garde issues in heart failure – the use of registry data, acute decompensated heart failure, device therapy, mechanical support for failing ventricles and a candid discussion of palliative care. The busy clinician is likely to find that Therapeutic Strategies in Heart Failure provides a useful template to optimize outcomes in the management of heart failure.
Benefits:
- Explores current, emerging and future therapies for heart failure
- Summaries of alternative management approaches included
- Evidence-based solutions provided by experts in the field
Readership:
- Specialists in cardiology and internal medicine
- General physicians
- Hospital pharmacists
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Alzheimer Disease - New Drugs, Markets and Companies
Management of Heart Failure
Pain Therapeutics - Drugs, Markets and Companies
Drug Delivery in Cancer - Technologies, Markets and Companies
Cardiovascular Drug Delivery - Technologies, Markets and Companies
Antiviral Drugs: From Basic Discovery Through Clinical Trials
Cancer Drug Resistance
Asthma: Modern Therapeutic Targets
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies
Personalized Medicine - Scientific and Commercial Aspects
|
|
|
|
